Ethylphenidate
From Wikipedia, the free encyclopedia
Ethylphenidate
|
|
Systematic (IUPAC) name | |
ethyl 2-phenyl-2-piperidin-2-ylacetate | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C15H21NO2 |
Mol. mass | 247.33274 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | N/A |
Ethylphenidate is a stimulant drug. It is formed inside the body when alcohol is consumed alongside the ADHD medication methylphenidate, by transesterification in the liver.[1] Ethylphenidate formation appears to be more common when large quantities of methylphenidate and alcohol are consumed at the same time, such as in abuse or overdose scenarios.[2] This process is also known to occur when cocaine and alcohol are consumed together, forming cocaethylene.
Ethylphenidate is a more selective dopamine reuptake inhibitor than methylphenidate, having around the same potency as a dopamine reuptake inhibitor compared to the parent compound,[3] but significantly less activity as a noradrenaline reuptake inhibitor.[4]
[edit] References
- ^ Markowitz JS, DeVane CL, Boulton DW, Nahas Z, Risch SC, Diamond F, Patrick KS. Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol. Drug Metabolism and Disposition. 2000 Jun;28(6):620-4.
- ^ Markowitz JS, Logan BK, Diamond F, Patrick KS. Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion. Journal of Clinical Psychopharmacology. 1999 Aug;19(4):362-6.
- ^ Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE Jr, Middaugh LD. Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. Journal of Medicinal Chemistry. 2005 Apr 21;48(8):2876-81.
- ^ Williard RL, Middaugh LD, Zhu HJ, Patrick KS. Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity. Behavioural Pharmacology. 2007 Feb;18(1):39-51.